Intel's stock outlook has shifted, with the fair value estimate climbing from around $28.42 to $37.27 per share. This ...

Medpace Holdings has recently seen its consensus analyst price target rise from $456 to approximately $519. This reflects a higher estimated fair value as sentiment improves across the contract ...

OrthoPediatrics stock recently saw its consensus analyst price target lowered from $26.29 to $24.14. This change reflects a more cautious stance from the investment community. The adjustment comes ...

This is the time of year for Top 50 free agents lists and projections for salaries for those star players. The projections don’t necessarily line up with realit ...

Everything to Know about Macro and Markets Markets ended the volatile week in the red. The Dow Jones Industrial Average (DJIA ...